New gel shows promise for thinning hair in early trial
Disease control
Completed
This study tested a gel called PP405 for male and female pattern baldness. 78 adults used the gel or a placebo for 28 days, then everyone could use the real gel for 3 more months. The main goals were to check safety and how the body processes the drug.
Phase: PHASE2 • Sponsor: Pelage Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 09, 2026 12:10 UTC